OpenAI Exec Fidji Simo Takes Medical Leave, Highlighting Tech's Expansive Demands

Simo's POTS diagnosis and leave of absence shine a light on the challenges women leaders face in the tech industry.

Apr. 6, 2026 at 5:52pm

A highly detailed, glowing 3D illustration of a complex neural network or AI infrastructure, rendered in a palette of neon cyan and magenta lights against a dark, shadowy background, conveying the powerful yet fragile nature of advanced AI systems.The expansive responsibilities of leading AI deployment at a rapidly growing tech giant can take a toll, even on the most resilient executives.Seattle Today

Fidji Simo, the CEO of AGI Deployment at OpenAI, is taking medical leave from the company after pushing herself too hard while navigating her neuroimmune condition POTS. Simo's expansive role at OpenAI, which has grown far beyond her initial 'CEO of Applications' title, underscores the immense demands placed on women leaders in the tech industry, especially when they are also managing serious health issues.

Why it matters

Simo's situation highlights the challenges that women executives, especially those with chronic health conditions, face in the high-pressure world of tech. Her transparency about her POTS diagnosis and the need to prioritize her health could help raise awareness about the realities of managing complex medical issues while leading a major company.

The details

Since joining OpenAI in mid-2025, Simo's responsibilities have grown exponentially. What started as the 'CEO of Applications' role has evolved into overseeing much of the company's core business, including the introduction of advertising into ChatGPT, the creation of an AI 'superapp,' the launch of ChatGPT Health, and the acquisition of the tech news show TBPN. Simo has been navigating these demands while also managing her POTS, a neuroimmune condition that she has long discussed publicly.

  • Simo joined OpenAI in mid-2025.
  • Simo experienced a POTS relapse a few weeks before starting at OpenAI.
  • Simo has been postponing medical tests and new therapies to focus on her work.
  • Simo took time off for medical tests two weeks before her current leave.
  • OpenAI announced Simo's medical leave on April 6, 2026.

The players

Fidji Simo

The CEO of AGI Deployment at OpenAI, who is taking medical leave to address her POTS, a neuroimmune condition.

Sam Altman

The CEO of OpenAI, who is focusing on research and policy while Simo oversees much of the company's core business.

Greg Brockman

The co-founder of OpenAI, who will lead product in Simo's absence.

Sarah Friar

The CFO of OpenAI, who will take on aspects of Simo's work during her leave.

Kate Rouch

The CMO of OpenAI, who is stepping down to focus on her recovery from breast cancer.

Got photos? Submit your photos here. ›

What they’re saying

“For my entire time here, I've postponed medical tests and new therapies to stay completely focused on the job and not miss a single day of work. I took time off for the first time two weeks before the break for some medical tests, and it's now clear that I've pushed a little too far and I really need to try new interventions to stabilize my health.”

— Fidji Simo, CEO of AGI Deployment, OpenAI

“If there is one good thing that can come out of having my health issues exposed to the world, it's raising awareness for complex chronic conditions like POTS, MECFS, Long Covid or EDS. I have high hopes that AI will accelerate the path to cures, but patients cannot wait. Despite all the resources at my disposal and an incredible support system, I still couldn't avoid a medical leave. We need better solutions for all patients, now.”

— Fidji Simo, CEO of AGI Deployment, OpenAI

“You can't outwork your body. At a certain point, you have to be honest about your limits. I've reached mine.”

— Kate Rouch, Former CMO, OpenAI

What’s next

OpenAI has stated that it has a strong executive bench that is capable of executing in Simo's absence. Co-founder Greg Brockman will lead product, while CFO Sarah Friar, Chief Revenue Officer Denise Dresser, and Chief Strategy Officer Jason Kwon will all take on aspects of Simo's work.

The takeaway

Fidji Simo's medical leave from OpenAI highlights the immense demands and challenges that women leaders in the tech industry face, especially when managing serious health issues. Her transparency about her POTS diagnosis and the need to prioritize her health could help raise awareness about the realities of balancing high-powered careers and complex medical conditions.